Southpoint Capital Advisors LP Charles River Laboratories International, Inc. Transaction History
Southpoint Capital Advisors LP
- $4.43 Billion
- Q1 2024
A detailed history of Southpoint Capital Advisors LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Southpoint Capital Advisors LP holds 700,000 shares of CRL stock, worth $146 Million. This represents 4.28% of its overall portfolio holdings.
Number of Shares
700,000
Previous 1,000,000
30.0%
Holding current value
$146 Million
Previous $236 Million
19.77%
% of portfolio
4.28%
Previous 5.16%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
726Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.26 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.08 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$436 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$391 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$315 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.6B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...